BRIEF-Citius Oncology Signs U.S. Distribution Agreement With Mckesson To Support Lymphir Commercial Launch

Reuters
Oct 20
BRIEF-Citius Oncology Signs U.S. Distribution Agreement With Mckesson To Support Lymphir Commercial Launch

Oct 20 (Reuters) - Citius Oncology Inc CTOR.O:

  • CITIUS ONCOLOGY SIGNS U.S. DISTRIBUTION AGREEMENT WITH MCKESSON TO SUPPORT LYMPHIR™ COMMERCIAL LAUNCH

  • CITIUS ONCOLOGY INC - LYMPHIR COMMERCIAL LAUNCH PLANNED FOR Q4 2025

Source text: ID:nPn15xXh8a

Further company coverage: CTOR.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10